Sentara Infusion Services recalls CEFEPIME, (a) 2GM IN NS 100ML (b)8GM IN NS 400ML (c) 12GM IN NS 600ML, used with a Curlin or Home pump, Sentara Home Inf
Recalled February 22, 2023 · FDA recall D-0280-2023 · Sentara Infusion Services
Hazard
Lack of sterility assurance · FDA Class II
Units
71 bags total
Sold at
Dispensed to Patients Nationwide.
Description
Lack of sterility assurance
Product
CEFEPIME, (a) 2GM IN NS 100ML (b)8GM IN NS 400ML (c) 12GM IN NS 600ML, used with a Curlin or Home pump, Sentara Home Infusion Pharmacy Services, 535 Independence Pkwy, Ste 300, Chesapeake, VA 23320
Manufacturer(s)
Sentara Infusion Services
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →